0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Noninvasive fetal genotyping of single nucleotide variants and linkage analysis for prenatal diagnosis of monogenic disorders

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          High-cost, time-consuming and complex processes of several current approaches limit the use of noninvasive prenatal diagnosis (NIPD) for monogenic disorders in clinical application. Thus, a more cost-effective and easily implementable approach is required.

          Methods

          We established a low-cost and convenient test to noninvasively deduce fetal genotypes of the mutation and single nucleotide polymorphisms (SNPs) loci by means of targeted amplification combined with deep sequencing of maternal genomic and plasma DNA. The sequential probability ratio test was performed to detect the allelic imbalance in maternal plasma. This method can be employed to directly examine familial pathogenic mutations in the fetal genome, as well as infer the inheritance of parental haplotypes through a group of selected SNPs linked to the pathogenic mutation.

          Results

          The fetal mutations in 17 families with different types of monogenic disorders including hemophilia A, von Willebrand disease type 3, Duchenne muscular dystrophy, hyper-IgM type 1, glutaric acidemia type I, Nagashima-type palmoplantar keratosis, and familial exudative vitreoretinopathy were identified in the study. The mutations included various forms: point mutations, gene inversion, deletions/insertions and duplication. The results of 12 families were verified by sequencing of amniotic fluid samples, the accuracy of the approach in fetal genotyping at the mutation and SNPs loci was 98.85% (172/174 loci), and the no-call rate was 28.98% (71/245 loci). The overall accuracy was 12/12 (100%). Moreover, the approach was successfully applied in plasma samples with a fetal fraction as low as 2.3%.

          Conclusions

          We have shown in this study that the approach is a cost-effective, less time consuming and accurate method for NIPD of monogenic disorders.

          Supplementary Information

          The online version contains supplementary material available at 10.1186/s40246-022-00400-4.

          Related collections

          Most cited references34

          • Record: found
          • Abstract: found
          • Article: not found

          Presence of fetal DNA in maternal plasma and serum.

          The potential use of plasma and serum for molecular diagnosis has generated interest. Tumour DNA has been found in 'the plasma and serum of cancer patients, and molecular analysis has been done on this material. We investigated the equivalent condition in pregnancy-that is, whether fetal DNA is present in maternal plasma and serum. We used a rapid-boiling method to extract DNA from plasma and serum. DNA from plasma, serum, and nucleated blood cells from 43 pregnant women underwent a sensitive Y-PCR assay to detect circulating male fetal DNA from women bearing male fetuses. Fetus-derived Y sequences were detected in 24 (80%) of the 30 maternal plasma samples, and in 21 (70%) of the 30 maternal serum samples, from women bearing male fetuses. These results were obtained with only 10 microL of the samples. When DNA from nucleated blood cells extracted from a similar volume of blood was used, only five (17%) of the 30 samples gave a positive Y signal. None of the 13 women bearing female fetuses, and none of the ten non-pregnant control women, had positive results for plasma, serum or nucleated blood cells. Our finding of circulating fetal DNA in maternal plasma may have implications for non-invasive prenatal diagnosis, and for improving our understanding of the fetomaternal relationship.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus.

            Cell-free fetal DNA is present in the plasma of pregnant women. It consists of short DNA fragments among primarily maternally derived DNA fragments. We sequenced a maternal plasma DNA sample at up to 65-fold genomic coverage. We showed that the entire fetal and maternal genomes were represented in maternal plasma at a constant relative proportion. Plasma DNA molecules showed a predictable fragmentation pattern reminiscent of nuclease-cleaved nucleosomes, with the fetal DNA showing a reduction in a 166-base pair (bp) peak relative to a 143-bp peak, when compared with maternal DNA. We constructed a genome-wide genetic map and determined the mutational status of the fetus from the maternal plasma DNA sequences and from information about the paternal genotype and maternal haplotype. Our study suggests the feasibility of using genome-wide scanning to diagnose fetal genetic disorders prenatally in a noninvasive way.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              The hemophilias--from royal genes to gene therapy.

                Bookmark

                Author and article information

                Contributors
                wangxuefeng6336@hotmail.com
                chensongc@hotmail.com
                chenming_xu2006@163.com
                Journal
                Hum Genomics
                Hum Genomics
                Human Genomics
                BioMed Central (London )
                1473-9542
                1479-7364
                27 July 2022
                27 July 2022
                2022
                : 16
                : 28
                Affiliations
                [1 ]GRID grid.16821.3c, ISNI 0000 0004 0368 8293, Department of Laboratory Medicine, Ruijin Hospital, , Shanghai Jiaotong University School of Medicine, ; Shanghai, People’s Republic of China
                [2 ]GRID grid.8547.e, ISNI 0000 0001 0125 2443, Obstetrics and Gynecology Hospital, Institute of Reproduction and Development, , Fudan University, ; Shanghai, People’s Republic of China
                [3 ]Genesky Diagnostics (Suzhou) Inc., 218 Xinghu St, Suzhou, Jiangsu People’s Republic of China
                [4 ]GRID grid.16821.3c, ISNI 0000 0004 0368 8293, International Peace Maternity and Child Health Hospital, School of Medicine, , Shanghai Jiao Tong University, ; Shanghai, People’s Republic of China
                [5 ]Shanghai Key Laboratory of Embryo Original Disorders, Shanghai, People’s Republic of China
                [6 ]GRID grid.16821.3c, ISNI 0000 0004 0368 8293, Collaborative Innovation Center of Hematology, , Shanghai Jiaotong University School of Medicine, ; Shanghai, People’s Republic of China
                [7 ]Shanghai Academy of Experimental Medicine, Shanghai, People’s Republic of China
                [8 ]GRID grid.506261.6, ISNI 0000 0001 0706 7839, Research Units of Embryo Original Diseases, , Chinese Academy of Medical Sciences (No. 2019RU056), ; Shanghai, China
                Article
                400
                10.1186/s40246-022-00400-4
                9327225
                ad77228a-571a-4c3e-bb46-708dca3a93ff
                © The Author(s) 2022

                Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

                History
                : 22 December 2021
                : 4 July 2022
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/501100001809, National Natural Science Foundation of China;
                Award ID: 81971344
                Award ID: 81771638
                Award ID: 81901495
                Funded by: National Key R&D Program of China
                Award ID: 2018YFC1004900
                Award Recipient :
                Funded by: Shanghai Municipal Commission of Science and Technology Program
                Award ID: 21Y21901002
                Award Recipient :
                Funded by: Shanghai Municipal Health Commission
                Award ID: GW-10.1-XK07
                Award Recipient :
                Funded by: the Shanghai “Rising Stars of Medical Talent” Youth Development Program Clinical Laboratory Practitioners Program
                Award ID: 201972
                Award Recipient :
                Funded by: Shanghai Municipal Commission of Health and family planning
                Award ID: 202140110, 20215Y0216
                Award Recipient :
                Categories
                Research
                Custom metadata
                © The Author(s) 2022

                Genetics
                cell-free dna,fetal genotyping,prenatal diagnosis,massively parallel sequencing,monogenic disorder

                Comments

                Comment on this article